Covid19
Showing NaN - NaN of 6
Covid19 Trial in France (Camostat Mesylate, Placebo)
Terminated
- Covid19
- Camostat Mesylate
- Placebo
-
Argenteuil, France
- +5 more
Jan 27, 2022
Caused by Biomarkers in Severe Forms of COVID-19 Pneumonia
Terminated
- Community-acquired Pneumonia
- Covid19
- Blood samples
-
Paris, Ile De France, France
- +1 more
Dec 30, 2021
Covid19, SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere Trial in France (Patch, Nicotine, Patch, Placebo)
Completed
- Covid19
- SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere
- Patch, Nicotine
- Patch, Placebo
-
Argenteuil, France
- +17 more
Jun 21, 2021
Pathological Findings of Fatal COVID-19
Recruiting
- SARS-CoV-2
- +4 more
- 2 post-mortem transcutaneous lung biopsies (1 anterior ; 1 posterior) using anatomical landmarks
-
Amiens, France
- +43 more
Apr 19, 2021
Multiple Myeloma, Covid19 Trial in France (blood sample analyses)
Recruiting
- Multiple Myeloma
- Covid19
- blood sample analyses
-
Amiens, France
- +54 more
Mar 17, 2021